Arkolith/Insider Trading/CADL/Form 4

Aguilar-Cordova Estuardo

10% OwnerCandel Therapeutics, Inc. (CADL) · full profile →Form 4 · filed Feb 25, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 21, 2025Disposed to issuer(D)11K$12.02$127K163K
Feb 21, 2025Disposed to issuer(D)11K$12.02$127K121K

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001873919-25-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML